CN100496502C - Preparation method of capsule drop for protecting eye - Google Patents

Preparation method of capsule drop for protecting eye Download PDF

Info

Publication number
CN100496502C
CN100496502C CNB2006100337449A CN200610033744A CN100496502C CN 100496502 C CN100496502 C CN 100496502C CN B2006100337449 A CNB2006100337449 A CN B2006100337449A CN 200610033744 A CN200610033744 A CN 200610033744A CN 100496502 C CN100496502 C CN 100496502C
Authority
CN
China
Prior art keywords
grams
vitamin
capsule
taurine
dissolved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100337449A
Other languages
Chinese (zh)
Other versions
CN1846704A (en
Inventor
黎秋萍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100337449A priority Critical patent/CN100496502C/en
Publication of CN1846704A publication Critical patent/CN1846704A/en
Application granted granted Critical
Publication of CN100496502C publication Critical patent/CN100496502C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The eye protecting capsule and dripping agent are compounded with vitamin A powder, taurine, glucose injection and distilled water. It is used to prevent eye diseases, nurse eyes, delay senility, raise eyesight, diminish inflammation, detocate, relieve pain and eliminate fatigue. It has simple recipe, determined curative effect, no side effect, convenient use, no pollution, simple preparation process and low cost.

Description

The capsule and dripping agent preparing process of eye-protecting
Technical field
The capsule and dripping agent preparing process of eye-protecting the invention belongs to the technical field of capsule watered pill preparation, makes the essential nourishing healthy drop of eyes more specifically to nutrient drug.
Background technology
Because the high speed development of modern science and technology, support the prosperity of fast industry, the main flow that see TV, play computer, the machine that operates video games has become people's work, study, life, everybody is excess eye-using unawares, the ground work of the long-term over loading of eyes, can not get maintenance, visual deterioration occurs at large, eye function is degenerated rapidly.Particularly ophthalmic such as adolescent myopia, amblyopia has tangible rising.Yet contain the external-applied capsules drop discovery as yet of vitamin A on the market for eye-protecting, the present invention fills up this blank, and the nutrient substance that adopts eyes to need most is made the medicament for the eyes agent, and the rehabilitation that helps eyes is bright.
Summary of the invention
The present invention has invented eye-protecting according to the gesture that modern's oculopathy rises rapidly, and prevention oculopathy improves vision, the specific nutrition medicament that has no side effect.
The present invention takes following measure to solve
The capsule and dripping agent preparing process of eye-protecting is formulated with vitamin A powder, taurine, glucose etc., is described in detail compound method of the present invention below.
Proportioning of the present invention is: vitamin A powder 20 grams-30 grams, taurine 18 grams-25 grams, heptyl paraben 0.3 gram-0.5 gram, glucose injection 280-320 gram, distilled water 680 grams-750 grams, best proportioning is: vitamin A powder 25 grams, taurine 20 grams, heptyl paraben 0.4 gram, glucose injection 300 grams, distilled water 700 grams (vitamin A powder content: 1 gram includes 3-Hydroxyretinol 2.5 ten thousand units).
Manufacture method of the present invention
The vitamin A powder is dissolved in the distillation warm water of 50 ℃ of 500 gram, stir, and it is close to add cap seal, soak into dissolving 1 hour-3 hours, with more than the cotton filter 23 of 5 metafiltration time, as far as possible with its wrap film elimination, get the vitamin A liquor, it is close stand-by to add cap seal.Taurine is dissolved in the distillation boiling water of 150 grams, after stirring and dissolving and the cooling,, stand-by with the cotton filter 23 of 5 metafiltration.Antiseptic agent methyl-p-hydroxybenzoate heptyl ester is dissolved in the distillation boiling water of 50 grams; at last filtering vitamin A liquor and taurine liquor, heptyl paraben solution, glucose injection are mixed together and mix thoroughly; reuse 5 metafiltration are cotton filters 2 times, promptly becomes the medicinal liquid of eye-protecting.The present invention is with the gelatin soft capsule of the dark coffee color lapping as medicinal liquid, with rotation Zhanang machined soft gelatin capsule automatically, adopts No. 2 microscler specifications.Soft gelatin capsule typing back ethanol clean surface oil stain, dry at normal temperatures, sort out inferior, underproof soft gelatin capsule behind dry the finishing, for making adhesion, on soft gelatin capsule, coat micro-Oleum Helianthi or soybean oil, package the irradiation sterilization of back, get final product with 200,000 rad (50.16C/kg) irradiation dose with "dead" pollution and noresidue amount.(note: in the operation after the dissolving of vitamin A powder, should be processed into the capsule ball as early as possible,, reduce the loss of vitamin A in order to avoid be exposed to for a long time in the air.)
Beneficial effect of the present invention
1, the present invention's vitamin A powder of adopting water solublity easily to absorb is a high-tech product, steady quality.Vitamin A changes retinal at retina, and the latter combines with the opsin and forms rhodopsin, to keep the vision in the low light level.During vitamin A deficiency, various oculopathy such as nyctalopia appear in the rhodopsin biosynthesis block.Vitamin A has the control differentiation of epithelial tissue and the effect of growth of inducing, by keeping normal function and structure is essential.
2, taurine has antiinflammatory, detoxifcation, analgesic effect, and to people's eyes organ, retina neural etc. have its growth promoter of promotion, keep the good action of normal function.Glucose can reduce intraocular pressure, eliminates the various pollution toxin of eyes, the antimicrobial effect of reducing swelling and alleviating pain is arranged, and also has the effect of moistening nutrition.
3, the present invention is the external drop, and all any foreign bodies enter at the moment, and eyes are functionally secreted tear, and tear reduces the content concn of medicine, so the vitamin A drop life-time service of low dose of the present invention also has no side effect.On the contrary, can play good efficacy to eyes " charging ".
4, medicament for the eyes agent of the present invention, often use can prevent ophthalmic, slow down aging, raising vision, resisting fatigue, the long-time computation of alleviation, reading or TV, wear asthenopia such as contact lens, dizzy ophthalmic bloated, the product external is for oral administration all can, to becoming the old man all can use, the patient that suffers from eye diseases also there is good help therapeutical effect from the child.
5, the present invention's gelatin of adopting dark coffee color is as lapping: one, can lucifuge guarantee the quality; Two, medicament does not contact with outside air, steady quality, and the shelf-life prolongs; Three, easy to use, no cross-contamination.(end at long point during use gets final product with acupuncture one osculum, preferably drips sooner or later and uses.)
6, formula for a product science of the present invention is simplified, processing technology advanced person, cost is low, effect is big,, be the love eyes, the rescue vision first-selected good medicine.
The specific embodiment:
Embodiment 1
Proportioning of the present invention is: vitamin A powder 20 grams-30 grams, taurine 18 grams-25 grams, heptyl paraben 0.3 gram-0.5 gram, glucose injection 280-320 gram, distilled water 680 grams-750 grams.
Manufacture method of the present invention is dissolved in the vitamin A powder in the distillation warm water of 50 ℃ of 500 gram, stir, and it is close to add cap seal, soak into dissolving 1 hour-3 hours,, try one's best its wrap film elimination with more than the cotton filter 23 of 5 metafiltration time, get the vitamin A liquor, it is close stand-by to add cap seal.Taurine is dissolved in the distillation boiling water of 150 grams, after stirring and dissolving and the cooling,, stand-by with the cotton filter 23 of 5 metafiltration.Antiseptic agent methyl-p-hydroxybenzoate heptyl ester is dissolved in the distillation boiling water of 50 grams; at last filtering vitamin A liquor and taurine liquor, heptyl paraben solution, glucose injection are mixed together and mix thoroughly; reuse 5 metafiltration are cotton filters 2 times, promptly becomes the medicinal liquid of eye-protecting.
The present invention is with the gelatin soft capsule of the dark coffee color lapping as medicinal liquid, with rotation Zhanang machined soft gelatin capsule automatically, adopts No. 2 microscler specifications.Soft gelatin capsule typing back ethanol clean surface oil stain, dry at normal temperatures, sort out inferior, underproof soft gelatin capsule behind dry the finishing, for making adhesion, on soft gelatin capsule, coat micro-Oleum Helianthi or soybean oil, package the irradiation sterilization of back, get final product with 200,000 rad (50.16C/kg) irradiation dose with "dead" pollution and noresidue amount.(note: in the operation after the dissolving of vitamin A powder, should be processed into the capsule ball as early as possible,, reduce the loss of vitamin A in order to avoid be exposed to for a long time in the air.)

Claims (1)

1; the capsule and dripping agent preparing process of eye-protecting; it is characterized in that: proportioning raw materials: vitamin A powder 20 grams-30 grams; taurine 18 grams-25 grams; glucose injection 280 grams-320 grams; heptyl paraben 0.3 gram-0.5 gram; distilled water 700 grams; with the vitamin A powder be dissolved in 50 ℃ 500 the gram distilled water in mix filtration thoroughly; adding close the soaking into of cap seal dissolved 1~3 hour; with more than the cotton filter 23 of 5 metafiltration time; as far as possible with its wrap film elimination; get the vitamin A liquor; it is close stand-by to add cap seal; taurine is dissolved in the distillation boiling water of 150 grams; after stirring and dissolving and the cooling; inferior stand-by with the cotton filter 23 of 5 metafiltration; antiseptic agent methyl-p-hydroxybenzoate heptyl ester is dissolved in the distillation boiling water of 50 grams; at last with filtering vitamin A liquor and taurine liquor; heptyl paraben solution; glucose injection is mixed together to be mixed thoroughly; reuse 5 metafiltration are cotton filters 2 times; with the gelatin soft capsule of dark coffee color lapping as medicinal liquid; with automatic rotation Zhanang machined soft gelatin capsule; adopt No. 2 microscler specifications; soft gelatin capsule typing back ethanol clean surface oil stain; dry at normal temperatures; sort out inferior underproof soft gelatin capsule behind dry the finishing; for making adhesion; on soft gelatin capsule, coat micro-Oleum Helianthi or soybean oil, package the back with irradiation sterilization.
CNB2006100337449A 2006-02-22 2006-02-22 Preparation method of capsule drop for protecting eye Expired - Fee Related CN100496502C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100337449A CN100496502C (en) 2006-02-22 2006-02-22 Preparation method of capsule drop for protecting eye

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100337449A CN100496502C (en) 2006-02-22 2006-02-22 Preparation method of capsule drop for protecting eye

Publications (2)

Publication Number Publication Date
CN1846704A CN1846704A (en) 2006-10-18
CN100496502C true CN100496502C (en) 2009-06-10

Family

ID=37076586

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100337449A Expired - Fee Related CN100496502C (en) 2006-02-22 2006-02-22 Preparation method of capsule drop for protecting eye

Country Status (1)

Country Link
CN (1) CN100496502C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101057695B (en) * 2007-05-22 2011-07-27 黎秋萍 Method for preparing nutrition supplementing beverage for eye

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
维生素A在眼表面作用的研究进展. 张蓓.国外医学眼科学分册,第28卷第3期. 2004
维生素A在眼表面作用的研究进展. 张蓓.国外医学眼科学分册,第28卷第3期. 2004 *

Also Published As

Publication number Publication date
CN1846704A (en) 2006-10-18

Similar Documents

Publication Publication Date Title
CN106038612A (en) Pharmaceutical composition for protecting eyesight as well as preparation method and application thereof
US20210259961A1 (en) Pharmaceutical composition for preventing and treating nitm and medical use thereof
CN102362924B (en) Medicinal composition for treating ophthalmic diseases and preparation method thereof
EP4324463A1 (en) Method and pharmaceutical composition for treating myopia
CN111803441A (en) Sodium hyaluronate eye drops containing 0.01% atropine and preparation method thereof
CN108125996A (en) It is a kind of for visual fatigue, dry eyes eye-drops preparations
CN102100665B (en) Eye drops containing vitamin E derivatives and preparation method thereof
CN100496502C (en) Preparation method of capsule drop for protecting eye
CN105106318A (en) Traditional Chinese medicine composition for treating xerophthalmia and preparation method of traditional Chinese medicine composition
CN100562340C (en) A kind of micro-emulsion type artificial tear
CN101129698B (en) Eye drops containing turmeric extractive and preparation method thereof
CN109865016A (en) A kind of pharmaceutical composition and its preparation method and application for treating xerophthalmia
CN112220784B (en) Grape seed hydrolyzed proanthocyanidin eye-protecting liquid for external application and preparation process thereof
CN102973594B (en) A kind of ophthalmic preparation and preparation method containing oxygen microcapsule
CN105902686A (en) In-situ gel eyewash containing nano-carbon crystals and preparation method thereof
Ayaki et al. Effects of rooster comb degradation product containing low-molecular hyaluronic acid (INJUV) in individuals with eye dryness; open-label tr. ial with no control group.
CN112843039A (en) MCT compensation meibum composition and preparation method thereof
CN105168237A (en) Compound gel moisturizing eye drops
CN111110817A (en) Traditional Chinese medicine composition for treating eye diseases, preparation method and application thereof
CN114469900B (en) Pharmaceutical composition for improving eye symptoms, preparation method and use method
JP7457780B2 (en) Eye relief application liquid and its preparation method
CN103948633A (en) Eye drops for treating oculopathy and preparation method thereof
CN102218083A (en) Drug composition for treating and preventing ophthalmic diseases
CN103550357B (en) A kind of control muscae volitantes collyrium and its production and use
CN106074626A (en) A kind of alleviate dry and astringent antibacterial liquid of eye and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090610

Termination date: 20120222